Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen

Oncology Reports

Volumn 15, Issue 5, 2006, Pages 1385-1390

  Furlong, Suzanne J ^a   Mader, Jamie S ^a   Hoskin, David W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Apoptosis; Breast cancer; Ceramide; Lactoferricin; Tamoxifen

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CERAMIDE; ESTROGEN RECEPTOR; LACTOFERRICIN B; LACTOFERRIN; TAMOXIFEN;

ANIMAL; APOPTOSIS; ARTICLE; BREAST; BREAST TUMOR; CATTLE; CELL CULTURE; DRUG EFFECT; EPITHELIUM CELL; HUMAN; METABOLISM; PATHOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BREAST; BREAST NEOPLASMS; CATTLE; CELLS, CULTURED; CERAMIDES; EPITHELIAL CELLS; HUMANS; LACTOFERRIN; RECEPTORS, ESTROGEN; TAMOXIFEN;

EID: 33744983537     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.5.1385     Document Type: Article

References (32)

1. Bellamy WR, Takase, M, Wakabayashi H, Kawase K and Tomita M: Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 73: 472-479, 1992.
2. Mader JS, Salsman J, Conrad DM and Hoskin DW: Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol Cancer Ther 4: 612-624, 2005. (Pubitemid 40601843)
3. Sakai T, Banno Y, Kato Y, Nozawa Y and Kawaguchi M: Pepsin-digested bovine lactoferrin induces apoptotic cell death with JNK/SAPK activation in oral cancer cells. J Pharmacol Sci 98: 41-48, 2005. (Pubitemid 40806126)
4. Eliassen LT, Berge G, Sveinbjornsson B, Svendsen JS, Vorland LH and Rekdal O: Evidence for a direct antitumor mechanism of action of bovine lactoferricin. Anticancer Res 22: 2703-2710, 2002. (Pubitemid 36069301)
5. Yoo YC, Watanabe S, Watanabe R, Hata K, Shimazaki K and Azuma I: Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn J Cancer Res 88: 184-190, 1997. (Pubitemid 27129646)
6. Gulbins E: Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol Res 47: 393-399, 2003.
7. Siskind S: Mitochondrial ceramide and the induction of apoptosis. J Bioenerg Biomembr 37: 143-153, 2005.
8. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA and Grant S: Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 91: 73-77, 1994. (Pubitemid 24018645)
9. Stover T and Kester M: Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. J Pharmacol Exp Ther 307: 468-475, 2003. (Pubitemid 37310658)
10. Mehta S, Blackinton D, Omar I, Kouttab N, Myrick D, Klostergaard J and Wanebo H: Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line. Cancer Chemother Pharmacol 46: 85-92, 2000. (Pubitemid 30624840)
11. Raisova M, Goltz G, Bektas M, Bielawska A, Riebeling C, Hossini AM, Eberle J, Hannun YA, Orfanos CE and Geilen CC: Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes. FEBS Lett 516: 47-52, 2002. (Pubitemid 34311931)
12. Rodriguez-Lafrasse C, Alphonse G, Aloy MT, Ardail D, Gerard JP, Louisot P and Rousson R: Increasing endogenous ceramide using inhibitors of sphingolipid metabolism maximizes ionizing radiation-induced mitochondrial injury and apoptotic cell killing. Int J Cancer 101: 589-598, 2002.
13. Lucci A, Han TY, Liu YY, Giuliano AE and Cabot MC: Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics. Int J Oncol 15: 541-546, 1999.
14. Charlier C, Chariot A, Antoine N, Merville MP, Gielen J and Castronovo V: Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells. Biochem Pharmacol 49: 351-358, 1995.
15. Yoo YC, Watanabe R, Koike Y, Mitobe M, Shimazaki K, Watanabe S and Azuma I: Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: involvement of reactive oxygen species. Biochem Biophys Res Commun 237: 624-628, 1997. (Pubitemid 27434736)
16. Matzinger P: The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 145: 185-192, 1991.
17. Sun XM, Snowden RT, Skilleter DN, Dinsdale D, Ormerod MG and Cohen GM: A flow cytometric method for the separation and quantitation of normal and apoptotic thymocytes. Anal Biochem 204: 351-356, 1992.
18. Dbaibo GS and Hannun YA: Signal transduction and the regulation of apoptosis: roles of ceramide. Apoptosis 3: 317-334, 1998. (Pubitemid 128514000)
19. Wang H, Charles AG, Frankel AJ and Cabot MC: Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells. Urology 61: 1047-1052, 2003. (Pubitemid 36547768)
20. Bleicher RJ and Cabot MC: Glucosylceramide synthase and apoptosis. Biochim Biophys Acta 1585: 172-178, 2002. (Pubitemid 36092082)
21. Utsugi T, Schroit AJ, Connor J, Bucana CD and Fidler IJ: Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51: 3062-3066, 1991.
22. Dobrzynska I, Szachowicz-Petelska, Sulkowski S and Figaszewski Z: Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol Cell Biochem 276: 113-119, 2005. (Pubitemid 41236216)
23. Yoon WH, Park HD, Lim K and Hwang BD: Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells. Biochem Biophys Res Commun 222: 694-699, 1996. (Pubitemid 26194814)
24. Burdick MD, Harris A, Reid CJ, Hollingsworth MA and Iwamura T: Oligosaccharides expressed on MUC1 by pancreatic and colon tumor cell lines. J Biol Chem 272: 24198-24202, 1997. (Pubitemid 27418619)
25. Vogel HJ, Schibli DJ, Jing W, Lohmeier-Vogel EM, Epand RF and Epand RM: Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem Cell Biol 80: 49-63, 2002. (Pubitemid 34194228)
26. Stover TC, Sharma A, Robertson GP and Kester M: Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res 11: 3465-3474, 2005. (Pubitemid 40627901)
27. Top D, de Antueno R, Salsman J, Corcoran J, Mader J, Hoskin D, Touhami A, Jericho MH and Duncan R: Liposome reconstitution of a minimal protein-mediated membrane fusion machine. EMBO J 24: 2980-2988, 2005. (Pubitemid 41486335)
28. Pettus BJ, Chalfant CE and Hannun YA: Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 1585: 114-125, 2002. (Pubitemid 36092075)
29. Lucci A, Cho WI, Han TY, Giuliano AE, Morton DL and Cabot MC: Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res 18: 475-480, 1998. (Pubitemid 28174859)
30. Kang Y, Cortina R and Perry RR: Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells. J Natl Cancer Inst 88: 279-284, 1996. (Pubitemid 26073372)
31. Mandlekar S, Yu R, Tan TH and Kong AN: Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res 60: 5995-6000, 2000.
32. + tumor cells by upregulating the expression of Fas ligand. Cancer Chemother Pharmacol 51: 284-290, 2003.